Back to company

Speciallægeselskabet Callisen ApS: Financial statements 2023

CVR: 31364620

Speciallægeselskabet Callisen ApS (CVR 31364620) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 9,359,566 and a net result of DKK 5,187,910 compared with DKK 2,168,694 the year before. That is an increase of 55.9% compared with the year before. Equity amounted to DKK 5,635,258. The solvency ratio was 33.7%. The company had 3 employees in the financial year.

Gross Profit
9,359,566 kr.
Profit/Loss
5,187,910 kr.
Equity
5,635,258 kr.
Total Assets
16,721,982 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-9.4 mio.5.2 mio.5.6 mio.3
2022-6 mio.2.2 mio.2.4 mio.2
2021-8.1 mio.5.1 mio.5.3 mio.2
2020-3.7 mio.2.2 mio.2.7 mio.3
2019-4.4 mio.1.8 mio.2.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Speciallægeselskabet Callisen ApS: The 2022 annual report is outJan 11, 2023

Speciallægeselskabet Callisen ApS has published its annual report for 2022. Gross profit came to DKK 6,003,688, and the net result was DKK 2,168,694.

About Speciallægeselskabet Callisen ApS

Speciallægeselskabet Callisen ApS is a Danish company of the type Anpartsselskab based in Viborg, founded in 2008. The company is registered under the industry Speciallægers aktiviteter. The management consists of Ali Kehler. The company is owned by Speciallægeholdingselskabet Medic ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 10,518,082 and a net result of DKK 5,451,381 compared with DKK 3,559,058 the year before. Equity amounted to DKK 10,377,723.